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IntroductIon
Inflammatory myofibroblastic tumor (IMT) of the lung 
is a rare, usually solitary lesion. IMTs are considered 
as benign true tumors, though some authors regard 
these lesions as low-grade sarcomas. The behavior of 
these lesions is unpredictable and complete resection 
should be considered as the treatment of choice1,2.
Herein we describe a case of multiple, bilateral 
IMTs of the lung in a 70 year-old asymptomatic wom-
an, where diagnosis was established by CT guided core 
biopsy. To our knowledge, only 10 cases of bilateral 
IMTs have been reported in 6 case series3-8, and only 2 
cases of pulmonary IMT were correctly diagnosed by 
CT guided biopsy1.
case report
A 70 year-old asymptomatic woman with inciden-
tally found bilateral lung lesions during pre-operative 
control was referred to our department for CT (Fi-
gure 1A). Physical examination was unremarkable. 
Contrast-enhanced CT demonstrated 3 lung lesions· 
1 lesion of 11 mm in the right upper lobe, 1 lesion 
of 41mm in the lingula and 1 lesion of 55 mm in the 
left lower lobe. The rest lung parenchyma was normal 
and no mediastinal lymph nodes were demonstrated 
(Figure 1A-D).
Due to suspicion of metastatic disease, the patient 
was referred for CT guided percutaneous core biop-
sy. The lesion in the lingula was considered to have 
the easiest access for biopsy and 4 tissue shamples 
were obtained with an 18 Gauge cutting needle us-
ing the coaxial technique (Temno;Evolution;Cardinal 
Health;Orlando) (Figure 1E). Pathological examina-
tion was performed by two pathologists (I.E, A.F) and 
demonstrated bundles of collagen fibers and the char-
acteristic spindle-cells, which at immunohistochemis-
try were positive in vimentin and smooth muscle actin 
(SMA) and negative in CD34 and BCL-2. There were 
also areas of chronic inflammatory infiltrations with 
the presence of lymphocytes and plasma cells. Lung 
parenchyma with inflammation was also found adja-
cent to the lesion in some tissue specimens (Figure 
1G-I). These findings were consistent with lung IMT. 
A second biopsy of the lesion in the left lower lobe 
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was performed some weeks later in order to confirm 
the nature of the lesion and to exclude coexistence of 
malignancy. Performing a posterior approach in order 
to avoid transversing the interlobar fissure, 4 tissue 
shamples were obtained with the same technique as 
described above (Figure 1F). Specimens were exam-
ined by the same pathologists and demonstrated the 
same histological findings with the first lesion. The 
lesion in the right upper lobe was considered as IMT 
without biopsy.
The patient after being informed about the dis-
ease chose not to be operated or receive any treatment 
since she was completely asymptomatic, and she was 
advised to have a chest CT scan every 6 months. One 
year after the initial diagnosis, the lesions remained 
unchanged in follow up CT, and the patient was as-
ymptomatic.
dIscussIon
IMT of the lung is a rare and not well known disease, 
accounting for 0,7-1 % of all thoracic tumors, while 
in children under 16 years, IMT is the most common 
primary tumor1,9-11. Other terms used for IMT include 
inflammatory pseudotumor, plasma cell granuloma, 
xanthogranuloma and fibrous histiocytoma1,12,13. 
IMTs of the lung can be found at any age group 
including childhood, but are more often found in 
patients younger than 40 years old .There is no sex 
predilection and in about half of the cases patients 
are asymptomatic and lesions are incidental findings 
in chest x-rays1,3,6,10,12. Symptomatic lung IMTs may 
cause dyspnea, cough, hemoptysis, chest pain, fever 
and general weakness5. Lung IMTs are usually solitary 
peripheral lung lesions and only 10 cases of multiple 
IMT‘s have been mentioned in 6 case series3-8. IMTs 
can be also found in multiple other anatomic locations 
including bladder, spleen, breast, pancreas, liver, co-
lon, spermatic cord, prostate, peripheral nerves, soft 
tissue and orbit2. 
It is believed that IMTs of the lung are the result 
of an unregulated response of inflammatory cells to 
tissue damage of chronic inflammation, related to 
pulmonary infection3,10. No genetic or environmen-
tal factors predispose for lung IMTs1. Although IMTs 
of the lung have been considered to be benign le-
sions, they have an unpredictable and variable clini-
cal course, with local invasion, local postoperative 
recurrences and distant metastases in some cases1,3,14. 
Chromosomal abnormalities detected in the younger 
age group IMTs suggest that lung IMT might be a true 
neoplasm rather than a purely inflammatory or reactive 
lesion14,15. One-third of cases show a 2p23 rearrange-
ment involving anaplastic lymphoma kinase (ALK), 
often fused with tropomyosin genes TPM3 and TPM4 
and the clarithrin heavy chain gene (CLTC)16. That is 
the reason why some authors consider these tumors as 
low-grade malignancies and propose a more aggres-
sive treatment1,12,17.
Figure 1. A. Preoperative chest x-ray, showing bilateral 
lung lesions, one small in the right upper lobe and two larg-
er in the left lung. 
B-D. Chest CT in lung window demonstrating the three 
lung lesions.
E-F. CT guided biopsy of the lesions.
G. Hyalinized connective tissue with scattered chronic in-
flammatory infiltrations. (Hematoxylin & Eosin X200).
H. Lung parenchyma adjacent to the lesion. (Hematoxylin 
& Eosin X100).
I. Smooth muscle actin positive spindle cells. (SMA x400).
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Cerfolio et al. divided IMTs into noninvasive and 
invasive. The invasive form is more often in pediatric 
patients (about 20%) who are at high risk for locore-
gional extension10. Lung IMTs may invade the medi-
astinum, the chest wall, the contralateral lung, large 
vascular structures, the left ventricle, the vertebra, the 
diaphragm, the thoracic inlet, the main bronchi and 
the carina1,18. In such cases, complex debulking op-
erations may be needed. Histologically lung IMT’s 
are characterized by the presence of myofibroblasts 
(spindle cells) with varying infiltrations of chronic in-
flammation and plasma cells12,19.
There are not specific guidelines about treatment 
of IMTs since these tumors are rare and clinical course 
varies. Most authors propose a more aggressive treat-
ment, with complete resection when possible, since 
patients with IMT’s are usually young and these tu-
mors often have malignant behavior1. Chemotherapy, 
steroid therapy and radiation therapy have been used 
by some authors with variable results1.
CT guided core biopsy or fine needle aspiration 
(FNA) have been used by some authors for the diag-
nosis of IMTs with disappointing results1,3,6,7,11,12. CT 
guided FNA has been described as non diagnostic 
for lung IMT’s3,12. CT guided core biopsy has also be 
described as non diagnostic in most cases6,7,11. Only 
Fabre et al. managed preoperative diagnosis of 2 lung 
IMTs by CT guided biopsy1. In our case, both biopsies 
that were studied by two pathologists were diagnostic 
for lung IMT. It seems that adequate tissue specimen is 
necessary for the diagnosis of lung IMTs. When small 
tissue specimen is taken by core biopsy and in samples 
from FNA, the mixture of chronic inflammatory cells 
and fibroblastic proliferation cannot lead to a definite 
and safe diagnosis because it is also found in a variety 
of other inflammatory and malignant lesions11,12.
Abbreviations: Inflammatory myofibroblastic tumor (IMT), 
computed tomography (CT), fine needle aspiration (FNA).
ΠΕΡΙΛΗΨΗ: Οι φλεγμονώδεις μυοϊνωβλαστικοί όγκοι (ΦΜΟ) του πνεύμονα είναι σπάνιες, συνήθως μονήρεις πνευμο-
νικές βλάβες οι οποίες σήμερα θεωρούνται ως αληθή νεοπλάσματα με απρόβλεπτη εξέλιξη. Περιγράφουμε μια περίπτωση 
πολλαπλών, αμφοτερόπλευρων ΦΜΟ του πνεύμονα σε μια 70χρονη ασυμπτωματική γυναίκα όπου η διάγνωση τέθηκε με 
κατευθυνόμενη βιοψία με τη βοήθεια του αξονικού τομογράφου. Εξ’ όσων γνωρίζουμε, λιγότερες από 10 περιπτώσεις αμ-
φοτερόπλευρων ΦΜΟ έχουν αναφερθεί και μόλις σε 2 περιπτώσεις η κατευθυνόμενη βιοψία έθεσε την ορθή διάγνωση.
Λέξεις Κλειδιά: Φλεγμονώδης μυοϊνωβλαστικός όγκος, Φλεγμονώδης ψευδοόγκος, Αξονική τομογραφία.
Ασυνήθης περίπτωση πολλαπλών φλεγμονωδών μυοϊνωβλαστικών όγκων πνεύμονα.
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